{"dataset":{"dimension":{"STATISTIC":{"label":"Statistic","category":{"index":{"PMM11C01":0},"label":{"PMM11C01":"Liabilities"},"unit":{"PMM11C01":{"base":"Euro billion"}}}},"TLIST(A1)":{"label":"Year","category":{"index":{"2019":0,"2020":1,"2021":2,"2022":3,"2023":4,"2024":5,"2025":6},"label":{"2019":"2019","2020":"2020","2021":"2021","2022":"2022","2023":"2023","2024":"2024","2025":"2025"}}},"C04708V05496":{"label":"Type of Liabilities","category":{"index":{"10":0,"20":1,"-":2},"label":{"10":"Debt instruments","20":"Equity","-":"Total liabilities"}}},"role":{"metric":["STATISTIC"],"time":["TLIST(A1)"]},"id":["STATISTIC","TLIST(A1)","C04708V05496"],"size":[1,7,3]},"label":"Liabilities in Pharmaceutical and Medical Manufacturing","source":"Central Statistics Office, Ireland","updated":"2026-09-24T11:00:00Z","value":[183.02,145.1,328.12,160.91,256.45,417.36,193.17,279.58,472.76,210.51,322.39,532.91,249.83,191.16,440.98,238.24,230.25,468.49,211.0,225.42,436.43]}}